Sunday, January 17, 2016 2:53:03 PM
Amphastar filed a brief requesting a rehearing. I just glanced at it, will read it more careful soon. But on a five minute review, it seems to be a rehash of old arguments. Here is a link to the brief.
https://www.dropbox.com/s/g9flccxms03spjv/Amphastar%20hearing%20petition.pdf?dl=0
In theory, Momenta also had the right to petition for a rehearing, they might've done that with respect to the Teva part of the decision (TEVA prevailed on the independent ground that they manufacture outside the US and arguably the statute language requires that the infringed patent be used to "make" the product -- at least that's my recollection of the Court's holding). But Momenta did not file a petition.
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM